TKIs and transplant for chronic myeloid leukemia

被引：0

作者：

Litzow, Mark R. ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA

来源：

LEUKEMIA RESEARCH | 2010年 / 34卷 / 02期

关键词：

CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; CELL TRANSPLANTATION; CHRONIC PHASE; PHILADELPHIA-CHROMOSOME; IMATINIB; THERAPY; INTOLERANCE; RESISTANCE; RESPONSES;

D O I：

10.1016/j.leukres.2009.07.018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：137 / 138

页数：2

共 11 条

[1] Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib [J].

Breccia, Massimo ;

Palandri, Francesca ;

Iori, Anna Paola ;

Colaci, Elisabetta ;

Latagliata, Roberto ;

Castagnetti, Fausto ;

Torelli, Giovanni Fernando ;

Usai, Sara ;

Valle, Veronica ;

Martinelli, Giovanni ;

Rosti, Gianantonio ;

Foa, Robin ;

Baccarani, Michele ;

Alimena, Giuliana .

LEUKEMIA RESEARCH, 2010, 34 (02) :143-147

[2] Imatinib for newly diagnosed patients with chronic myeloid leukemia: Incidence of sustained responses in an intention-to-treat analysis [J].

de Lavallade, Hugues ;

Apperley, Jane F. ;

Khorashad, Jamshid S. ;

Milojkovic, Dragana ;

Reid, Alistair G. ;

Bua, Marco ;

Szydlo, Richard ;

Olavarria, Eduardo ;

Kaeda, Jaspal ;

Goldman, John M. ;

Marin, David .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (20) :3358-3363

[3] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[4] Translation of the Philadelphia chromosome into therapy for CML [J].

Druker, Brian J. .

BLOOD, 2008, 112 (13) :4808-4817

[5] Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia [J].

Giralt, Sergio A. ;

Arora, Mukta ;

Goldman, John M. ;

Lee, Stephanie J. ;

Maziarz, Richard T. ;

McCarthy, Philip L. ;

Sobocinski, Kathleen A. ;

Horowitz, Mary M. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) :461-467

[6] Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia [J].

Hehlmann, Ruediger ;

Berger, Ute ;

Pfirrmann, Markus ;

Heimpel, Hermann ;

Hochhaus, Andreas ;

Hasford, Joerg ;

Kolb, Hans-Jochem ;

Lahaye, Tanja ;

Maywald, Ole ;

Reiter, Andreas ;

Hossfeld, Dieter K. ;

Huber, Christoph ;

Loeffler, Helmut ;

Pralle, Hans ;

Queisser, Wolfgang ;

Tobler, Andreas ;

Nerl, Christoph ;

Solenthaler, Max ;

Goebeler, Mariele E. ;

Griesshammer, Martin ;

Fischer, Thomas ;

Kremers, Stephan ;

Eimermacher, Hartmut ;

Pfreundschuh, Michael ;

Hirschmann, Wolf-Dietrich ;

Lechner, Klaus ;

Wassmann, Barbara ;

Falge, Christiane ;

Kirchner, Hartmut H. ;

Gratwohl, Alois .

BLOOD, 2007, 109 (11) :4686-4692

[7] Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib [J].

Hochhaus, A. ;

Baccarani, M. ;

Deininger, M. ;

Apperley, J. F. ;

Lipton, J. H. ;

Goldberg, S. L. ;

Corm, S. ;

Shah, N. P. ;

Cervantes, F. ;

Silver, R. T. ;

Niederwieser, D. ;

Stone, R. M. ;

Dombret, H. ;

Larson, R. A. ;

Roy, L. ;

Hughes, T. ;

Mueller, M. C. ;

Ezzeddine, R. ;

Countouriotis, A. M. ;

Kantarjian, H. M. .

LEUKEMIA, 2008, 22 (06) :1200-1206

[8] Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia - No evidence for increased transplant-related toxicity [J].

Jabbour, Elias ;

Cortes, Jorge ;

Kantarjian, Hagop ;

Giralt, Sergio ;

Andersson, Borje S. ;

Giles, Francis ;

Shpall, Elizabeth ;

Kebriaei, Partow ;

Champlin, Richard ;

de Lima, Marcos .

CANCER, 2007, 110 (02) :340-344

[9] Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance [J].

Kantarjian, Hagop M. ;

Giles, Francis ;

Gattermann, Norbert ;

Bhalla, Kapil ;

Alimena, Giuliana ;

Palandri, Francesca ;

Ossenkoppele, Gert J. ;

Nicolini, Franck-Emmanuel ;

O'Brien, Stephen G. ;

Litzow, Mark ;

Bhatia, Ravi ;

Cervantes, Francisco ;

Haque, Ariful ;

Shou, Yaping ;

Resta, Debra J. ;

Weitzman, Aaron ;

Hochhaus, Andreas ;

le Coutre, Philipp .

BLOOD, 2007, 110 (10) :3540-3546

[10] Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia [J].

Lee, Stephanie J. ;

Kukreja, Manisha ;

Wang, Tao ;

Giralt, Sergio A. ;

Szer, Jeffrey ;

Arora, Mukta ;

Woolfrey, Ann E. ;

Cervantes, Francisco ;

Champlin, Richard E. ;

Gale, Robert Peter ;

Halter, Joerg ;

Keating, Armand ;

Marks, David I. ;

McCarthy, Philip L. ;

Olavarria, Eduardo ;

Stadtmauer, Edward A. ;

Abecasis, Manuel ;

Gupta, Vikas ;

Khoury, H. Jean ;

George, Biju ;

Hale, Gregory A. ;

Liesveld, Jane L. ;

Rizzieri, David A. ;

Antin, Joseph H. ;

Bolwell, Brian J. ;

Carabasi, Matthew H. ;

Copelan, Edward ;

Ilhan, Osman ;

Litzow, Mark R. ;

Schouten, Harold C. ;

Zander, Axel R. ;

Horowitz, Mary M. ;

Maziarz, Richard T. .

BLOOD, 2008, 112 (08) :3500-3507

← 1 2 →